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The role of CC chemokine ligand 3 (CCL3) in activation of dendritic cells (DCs) following mouse hepatitis virus (MHV) infection of the
central nervous system (CNS) was examined. The results indicate that CCL3 participates in an effective host response to MHV infection by
contributing to CD11c+CD11b+CD8a DC maturation, activation, and migration to cervical lymph nodes (CLN). Diminished CD8a DC
activation correlated with reduced IFN-g expression by virus-specific T cells accompanied by increased IL-10 production suggesting that
CCL3 contributes to an effective host response to viral infection by enhancing the T cell activation potential of DC.
D 2004 Elsevier Inc. All rights reserved.
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Introduction brain indicating that trafficking was impaired. Moreover,The CC chemokine ligand 3 (CCL3—macrophage
inflammatory protein-1a) is capable of activating mono-
cytes and lymphocytes and serves an important role in the
initial recruitment of these cells to tissues following
microbial infection (Cook et al., 1995; Domachowske et
al., 2000). In support of the importance for CCL3 in
imparting functional signals to T cells are data from our
laboratory demonstrating that instillation of mouse hep-
atitis virus (MHV) into the brains of CCL3/ mice results
in an inability to clear virus from the central nervous
system (CNS) (Trifilo et al., 2003). MHV-infected CCL3/
mice exhibited a significant reduction in the numbers of
infiltrating virus-specific CD8+ T cells present within the0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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activity of virus-specific CD8+ T cells was dramatically
reduced in the absence of CCL3 signaling. Taken together,
these data indicate that CCL3 signaling significantly
enhances the differentiation of primed CD8+ T cells into
effector cells that allows their release from secondary
lymphoid organs into circulation and effective migration to
the CNS. The present study was undertaken to characterize
potential mechanisms by which CCL3 signaling imparts
effector function to antigen-specific T cells following
MHV infection of the CNS. To further understand the
relationship between CCL3 signaling and T cell activation,
CCL3+/+ and CCL3/ mice were infected with MHV and
the presence and activation state of DC-like cells within
the brain and draining cervical lymph nodes (CLN)
determined. Our results delineate a CCL3-dependent path-
way of T cell activation that involves the maturation and
activation of a subpopulation of (dendritic cells) DCs
(CD11c+CD11b+CD8a) within the CNS as well as
influencing the accumulation of these cells within the
CLN following MHV infection of the CNS.004) 8–15
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Characterization of CD11c+ cells within the CNS following
MHV infection of CCL3+/+ and CCL3/ mice
To characterize the populations of cells present within
the CNS of MHV-infected mice, cells were harvested at
days 0, 2, and 5 post-infection (p.i.) and immunopheno-
typed by flow cytometry. We chose to focus our attention
on markers that are associated with professional antigen
presenting cells such as DC as recent studies have indicated
DC-like cells can be detected within the brains under
inflammatory conditions (Fisher and Reichmann, 2001;
Fischer et al., 2000). Furthermore, we have previously
determined that CCL3 mRNA expression is detected within
the CNS early (b3 days) and therefore may participate in
the appearance of CD11c+ cells within the brain following
MHV infection (Trifilo et al., 2003). Therefore, we sought
to characterize the populations of CD11c+ cells within theFig. 1. Analysis of dendritic cells (DCs) within the brain following MHV infectio
(day 2 p.i.) CCL3+/+ and CCL3/ mice and stained for CD11c+ and CD11b+ exp
or CD11c+CD11b (lower-right quadrant) and numbers indicate frequencies of ga
on CD11c+ cells. CD11c+CD11b+ cells from either MHV-infected CCL3+/+ or CC
DEC205 while expression of both CD8a and DEC205 was readily detectable on C
day 2 p.i. (C) Total numbers of CD8a+ and CD8a DCs within the brains of MH
presented represent an average cell number derived from two separate experiments
cells isolated from brains of CCL3+/+ or CCL3/ mice at day 2 p.i. were gate
cytometry. The mean fluorescence intensity (MFI) for cells obtained from either C
D are representative of two separate experiments with a total of 10 mice for eachbrain following MHV infection of CCL3+/+ and CCL3/
mice. Results in Fig. 1A indicate the frequency of CD11c+
cells present within the CNS of naRve CCL3+/+ and CCL3/
mice is b1%. However, within 2 days following intra-
cranial infection with MHV, there is a marked increase in
the frequency of CD11c+ cells within the brains of both
strains of mice (Fig. 1A). Analysis of CD11b expression
revealed that approximately 75% of CD11c+ cells in both
CCL3+/+ and CCL3/ mice were also CD11b+ (Fig. 1A).
CD11c+CD11b+ cells isolated from the CNS of either
CCL3+/+ or CCL3/ mice expressed little to no CD8a or
DEC205 suggesting a phenotype similar to myeloid
derived DC (CD11c+, CD11b+, CD8a, DEC205) (Fig.
1B) (Anjuere et al., 1999; Henri et al., 2001). Increased
CD8a and DEC205 expression on CD11c+CD11b cells
indicated that the majority of the remaining CD11c+ cells
present within the brain were similar phenotypically to
lymphoid derived DC (CD11c+, CD11b, CD8a+) (Fig.
1B) (Anjuere et al., 1999; Henri et al., 2001). Although then. (A) Cells were isolated from the brains of uninfected (naRve) or infected
ression. Gated populations represent CD11c+CD11b+ (upper-right quadrant)
ted cells within the isolated population. (B) CD8a and DEC205 expression
L3/ mice at day 2 p.i. did not express detectable levels of either CD8a or
D11c+CD11b cells present within the brains of both populations of mice at
V or sham-infected CCL3+/+ and CCL3/ mice at days 2 and 5 p.i. Data
with a minimum of 10 mice analyzed per experimental group. (D) CD8a
d upon and CD80, CD86, and CD40 expression was determined by flow
CL3+/+ or CCL3/ mice is indicated. Flow data shown in panels A, B, and
experimental condition.
M.J. Trifilo, T.E. Lane / Virology 327 (2004) 8–1510remaining CD11c+CD11bCD8a population was not
further characterized, it is likely that these cells may be
plasmacytoid in origin (CD11c+CD11bCD8aB220+) or
consist of a yet to be defined population of DC.
Comparison of the total numbers of CD8a+ cells within
the brains of MHV-infected CCL3+/+ and CCL3/ mice
revealed no dramatic differences between the two pop-
ulations of mice at either 2 or 5 days p.i. (Fig. 1C). In
contrast, numbers of CD8a cells were increased by
approximately 30% within the brains of MHV-infected
CCL3+/+ mice as compared to CCL3/ mice at day 2 p.i.
However, by day 5 p.i., there were increased numbers of
CD8a cells present in the brains of CCL3/ mice when
compared to CCL3+/+ mice. In attempt to better evaluate
the activation state of CD11c+ cells within the brains of
MHV-infected mice, we next determined the expression
levels of co-stimulatory molecules CD80 (B-7.1), CD86
(B-7.2), and CD40 on CD8a cells within the CNS of
CCL3+/+ and CCL3/ mice. We chose to focus on this
subpopulation of DCs in more detail as this clearly was the
predominant DC population within the brains of infected
mice suggesting a potentially more important role in
defense. Analysis of CD8a cells isolated from the brains
of CCL3+/+ mice at day 2 p.i. revealed these cells
expressed detectable levels CD80, CD86, and CD40 as
determined by measuring the mean fluorescence intensity
(MFI) (Fig. 1D). Although MHV infection of CCL3/
mice also resulted in enhanced expression of CD86 on the
surface of CD8a cells, the MFI for both CD80 and CD40
was dramatically reduced as compared to CD8a cells
within the brain of CCL3+/+ mice at day 2 p.i. (Fig. 1D).
Together, these results indicate that although CCL3
signaling is not required for the appearance of DC-like
cells within the brain, expression of the co-stimulatory
molecules CD40 and CD80 is muted in the absence of
CCL3 signaling.
Characterization of CD11c+ cells within the CLN of
MHV-infected CCL3+/+ and CCL3/ mice
Following MHV infection of the CNS, virus-specific T
cells are present within the CLN suggesting that the bulk of
virus-specific T cells are generated in the periphery (Marten
et al., 2003). Therefore, the accumulation of CD11c+ cells
within the CLN of infected CCL3+/+ and CCL3/ mice
was determined. Before infection, CD11c+ cells expressing
a myeloid DC phenotype (CD11c+ CD11b+) and lymphoid
DC phenotype (CD11c+ CD11b) were present within the
CLN of both CCL3+/+ and CCL3/ mice at an approximate
1:2 ratio, respectively (Fig. 2A). However, within 2 days of
MHV infection of the CNS, the frequency of CD11c+-
CD11b+ DCs, but not CD11c+CD11b DCs, dramatically
increased within the CLN of CCL3+/+ mice (Fig. 2A).
Further analysis revealed that the CD11c+CD11b+ cell
population was CD8aDEC205 while the CD11c+-
CD11b population was CD8a+DEC205+ (Fig. 2B).Although the total number of CD8a cells increased within
the CLN of CCL3/ mice, there was an approximate 4-fold
reduction in total numbers of CD8a cells as compared to
CCL3+/+ mice at days 2 and 5 p.i. (Fig. 2C). Similar to the
brain, no difference in numbers of CD8a+ cells within the
CLN was detected at either days 2 or 5 p.i. (Fig. 2C).
Examination of co-stimulatory molecule expression on
CD8a DCs present within the CLN of CCL3+/+ mice
correlated with the increased expression of co-stimulatory
molecules CD40, CD80, CD86 as well as increased MHC I
and II expression when compared to sham-infected mice
(Figs. 2D and E). These data suggest that this population of
activated CD8a cells within the CLN is able to present
antigen and induce T cell differentiation within the CLN
following MHV infection of the CNS. Although CD8a
DCs isolated from the CLN of CCL3/ mice expressed
similar levels of CD80 and CD86 as compared to CCL3+/+
(determined by MFI), expression of CD40 as well as MHC I
and II were reduced as compared to CD8a cells isolated
from MHV-infected CCL3+/+ mice (Figs. 2D and E).
Cytokine secretion by CD11c+ cells
One mechanism by which DCs influence the T cell
response to infection is through the secretion of cytokines
that can subsequently polarize the immune response
towards either a Th1 or Th2 phenotype depending on the
antigenic challenge. To determine if CD8a DCs present
within the CLN of infected CCL3+/+ and CCL3/ mice
were capable of secreting either chemokines or cytokines
following MHV infection of the CNS, these cells were
isolated and production determined by ELISA. CCL3 was
readily detectable from CD8a DCs obtained from CCL3+/+
mice while CCL3 was not detected in supernatants
collected from CCL3/ CD8a DCs (Fig. 3). The
CCL3+/+ CD8a DC population secreted IL-12p70 with
low-level production of IL-10 (Fig. 3). In contrast, the
CD11c+ CD11b+ CD8a cells isolated from CCL3/ mice
secreted approximately 3-fold less IL-12p70 while IL-10
secretion was increased by 5-fold as compared to cells from
CCL3+/+ mice (Fig. 3).
Altered cytokine production in CCL3/ T cells
We next evaluated the ability of T cells obtained from the
CLN of either MHV-infected CCL3+/+ or CCL3/ mice to
synthesize cytokines following exposure to defined viral
antigens. T cells were isolated from the CLN of CCL3+/+ and
CCL3/ mice at days 7 and 12 p.i. following intracranial
infection with MHV and stimulated with peptides corre-
sponding to either the immunodominant CD4 epitope
present within the matrix (M) glycoprotein at residues
133–147 (M133–147) or the immunodominant CD8 epitope
in the surface (S) glycoprotein spanning residues 510–518
(S510–518) and cytokine production by T cells determined
by intracellular cytokine staining (Castro and Perlman, 1995;
Fig. 2. Analysis of DCs within the CLN following MHV infection. (A) Cells were isolated from the CLNs of uninfected (naRve) or infected (day 2 p.i.) CCL3+/+
and CCL3/ mice and stained for CD11c+ and CD11b+ expression. Gated populations represent CD11c+CD11b+ (upper-right quadrant) or CD11c+CD11b
(lower-right quadrant) and numbers indicate frequencies of gated cells within the isolated population. (B) CD8a and DEC205 expression on CD11c+ cells.
CD11c+CD11b+ cells from either CCL3+/+ or CCL3/ at day 2 p.i. did not express detectable levels of either CD8a or DEC205 while expression of both
CD8a and DEC205 was readily detectable on CD11c+CD11b cells present within the brains of both CCL3+/+ and CCL3/ mice at day 2 p.i. (C) Total
numbers of CD8a+ and CD8a DCs within the CLNs of MHVor sham-infected CCL3+/+ and CCL3/ mice at days 2 and 5 p.i. Data presented represent an
average cell number derived from two separate experiments with a minimum of 10 mice analyzed per experimental group. (D) CD8a cells obtained from
MHV-infected (day 2 p.i.) or sham mice were gated and the level of CD80, CD86, and CD40 expression was determined by flow cytometry. The MFI for cells
obtained from either CCL3+/+ or CCL3/ mice is indicated. (E) CD8a cells obtained from MHV-infected or sham mice were evaluated for expression of
MHC I and II. The MFI for staining of either MHC I or II is indicated in the histogram. Flow data shown in panels A, B, D, and E are representative of two
separate experiments with a total of 10 mice for each experimental condition.
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similar frequencies of CD4+ and CD8+ T cells from CCL3+/+
mice produced IFN-g at days 7 and 12 p.i. Both CD4+ and
CD8+ CCL3+/+ T cells also secreted IL-2 following specific
peptide exposure at day 7, although expression was limited
to the acute stage of MHV infection as the frequency of IL-2-
producing cells was reduced at day 12 p.i. (Table 1). In
contrast, the frequency of CD4+ and CD8+ T cells isolated
from CCL3/ mice secreting IFN-g following peptide
stimulation was dramatically reduced. Expression of IL-2 by
CCL3/ T cells was comparable with CCL3+/+ mice at day
7 p.i. However, by day 12 p.i., the frequency of CCL3/ T
cells expressing IL-2 remained elevated as compared to
CCL3+/+ T cells (Table 1). In addition, only limited
frequencies of CCL3+/+ CD4+ and CD8+ T cells produced
IL-10 following MHV infection whereas CCL3/ CD4+
and CD8+ T cells displayed an overall increase in the
frequency of IL-10 (Table 1).The major findings of this study are (i) MHV infection of
the CNS results in the appearance of two distinct popula-
tions of CD11c+ cells each expressing markers characteristic
of lymphoid (CD11c+CD11bCD8a+DEC205+) and mye-
loid dendritic cells (CD11c+CD11b+CD8aDEC205), (ii)
the accumulation of CD8a DCs within the draining CLN
is reduced in the absence of CCL3 signaling, (iii) expression
of co-stimulatory molecules such as CD40 by CD8a DCs
within either the brain and CLN of MHV-infected CCL3/
mice is diminished suggesting that CCL3 signaling enhan-
ces expression of these molecules, and (iv) absence of
CCL3 signaling results in the re-direction of the T cell
response to viral antigens as determined by cytokine
production. These data support and extend recent studies
from our laboratory demonstrating an important role for
CCL3 in generating effector anti-viral T cells capable of
migrating to the brain in response to viral infection (Trifilo
et al., 2003).
Fig. 3. Cytokine and chemokine secretion by CD11c+ CD11b+ CD8a cells
isolated from mononuclear cells pooled from the CLN of MHV-infected
CCL3+/+ and CCL3/ mice at day 7 p.i. Supernatants were analyzed for
the production of IL-12p70, IL-10, and CCL3 by ELISA 24 h following
culture. A minimum of three to six mice per group were used for isolation
of cells and data presented indicate the average F SD. *P V 0.001.
Table 1
Frequency of cytokine-producing T cells present within draining cervical
lymph nodes following MHV infectiona
Mouse Day p.i. IFN-g IL-2 IL-10
CD4+ T cells CCL3+/+ 7 20 F 4 35 F 5 5 F 2
12 16 F 3 2 F 1 2 F 1
CCL3/ 7 b1b 39 F 3b 24 F 4c
12 b1b 34 F 5b 36 F 4c
CD8+ T cells CCL3+/+ 7 23 F 5 22 F 2 6 F 1
12 18 F 2 6 F 2 5 F 1
CCL3/ 7 5 F 2b 21 F 3b 20 F 2c
12 3 F 1b 31 F 5b 28 F 4c
Data represent two separate experiments with at least three mice per group,
n = 6. Data are presented as average F SD.
a Cytokine expression determined by pooling cells from draining CLN of
MHV-infected mice at defined times p.i. and pulsing with defined CD4+
epitope (M133–147) and CD8+ epitope (S510–518).
b P V 0.01. Decreased frequency of IFN-g secreting T cells and increased
frequency of IL-2 producing T cells following MHV infection of CCL3/
mice as compared to CCL3+/+ mice.
c P V 0.002. Increased frequency of IL-10 producing T cells in CCL3/
mice as compared to CCL3+/+ mice following MHV infection.
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secondary lymphoid organs is thought to be a key step
in the initiation of an adaptive immune response (Bancher-
eau and Steinman, 1998). Recent studies have indicated that
following infection of the CNS with Toxoplasma gondii,
CD11c+ cells are present within the brain and these cells
were able to stimulate the proliferation of naRve T cells
(Fisher and Reichmann, 2001). Similarly, our results also
indicate an increase in CD11c+ cells within the CNS
following viral infection, suggesting that these cells are
likely critical for successful T cell priming following
migration to draining lymph nodes. Whether these cells
are present within the CNS by differentiation of local
antigen presenting cells, or through migration of immature
DC has not been determined and is currently under
investigation. Regardless, our data imply that CCL3
expression and signaling contributes to the migration of
CD8a CD11c+ cells to secondary lymphoid tissue where
they participate in priming of T cells. In support of this, we
have shown that CCL3 is important in arming these cells
with the capability to optimally stimulate antigen-specific T
cells with the ability to fully differentiate into effector cells
(Trifilo et al., 2003). The data presented in this study
support and extend these observations and indicate that
these results may be the result of a combination of
diminished expression of both MHC class I and II, reduced
expression of CD40, as well as a shift in cytokine
production by CD8a cells. Indeed, CD40L:CD40 medi-
ated interactions between T cells and APC can enhance IL-
12 production by DC and blockade of this interaction has
been shown to result in reduced autoimmunity by down-regulating Th1 differentiation (Cella et al., 1996; Macatonia
et al., 1995). Accumulating evidence indicates that in
addition to driving virus-specific T cell proliferation, the
activation state of DCs can also directly influence the
effector function of T cells through the secretion of
proinflammatory cytokines (Fischer et al., 2000; Maldo-
nado-Lopez et al., 1999, 2001; Pulendran et al., 1999). For
example, following several viral and bacterial infections,
CD8a+ DCs have been shown to be able to secrete large
amounts of the proinflammatory cytokine IL-12 both in
vitro and in vivo and this results in a preferential expression
of Th1-associated cytokines, such as IFN-g by responding T
cells (Aliberti et al., 2000; Maldonado-Lopez et al., 1999,
2001; Pulendran et al., 1999; Reis e Sousa et al., 1997).
Until recently, the prevailing thought was that CD8a+ DCs
were primarily responsible for production of IL-12 and
contributing to a Th1 response. However, recent studies
have indicated that CD8a DCs also have the potential for
secreting IL-12 and influencing the T cell response (Doxsee
et al., 2003). Our studies clearly indicate that CD8a DCs
isolated from the draining CLN of MHV-infected CCL3+/+
mice secrete IL-12 suggesting that these cells help influence
a protective Th1-mediated immune response characterized
by the majority of antigen-specific T cells expressing IFN-g
rather than IL-10 (Table 1). In stark contrast is the data
indicating that CD8a DCs present in the CLN of infected
CCL3/ mice predominantly secrete IL-10 and this
correlates with limited IFN-g expression and enhanced
expression of the Th2-associated cytokine IL-10 (Table 1).
Therefore, the data indicate that cytokine production, rather
than the type of CD11c+ cell, may control the predominant
T cell immune response within the CLN. Taken together,
these data point to an important role in CCL3 expression in
linking innate and adaptive immune responses following
viral infection of the CNS by contributing to the activation
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CNS to lymphoid tissues as well as the expression of both
co-stimulatory molecules and cytokine production. How-
ever, it is important to note that there is the possibility of
other chemokines and chemokine receptors participating in
DC responses following viral infection. Indeed, the CC
chemokine receptor 2 (CCR2) is expressed on professional
APC including macrophages and DCs and is thought to
contribute to defense following microbial challenge by
enhancing recruitment as well as production of antimicro-
bial products such as TNF-a and NO by these cells (Luster,
2002; McColl, 2002; Serbina et al., 2003). In addition, the
absence of CCR2 signaling results in diminished trafficking
and accumulation of dendritic cells within secondary
lymphoid tissues following antigenic challenge (Peters et
al., 2000, 2001; Sato et al., 2000). Studies are currently in
progress to evaluate the contributions of additional chemo-
kine signaling pathways that may also participate in DC
activation and migration following coronavirus infection.
In conclusion, the studies presented support and extend
previous work from our laboratory indicating an important
role for chemokines in the migration of T cells into the CNS
following MHV infection (Chen et al., 2001; Glass et al.,
2001; Liu et al., 2001). Here, we have demonstrated a novel
role for the chemokine CCL3 in enhancing the accumulation
and activation of CD8a DCs within secondary lymphoid
tissue and this correlates with altered T cell activation and
differentiation following viral infection. These results
indicate that CD8a DCs likely function in an APC-like
role within the CLN following MHV infection and that these
cells rely upon chemokine instruction to activate T cells. At
a more fundamental level, the results presented demonstrate
that chemokines serve as critical upstream signals in the
innate immune response that later is important with regards
to the initiation of a protective adaptive immune responses
to viral infection.Materials and methods
Animals and virus
MHV J2.2V-1 was kindly provided by J. Fleming (U.
Wisconsin). CCL3/ and CCL3+/+ mice (C57BL/6, H-2b)
were purchased from Jackson Laboratories (Bar Harbor,
ME). Mice were anesthetized by inhalation of methoxy-
flurane (Pitman-Moor Inc., Washington Crossing, NJ) and
injected intracranially (i.c.) with 1000 PFU MHVJ2.2V-1
suspended in 30 Al sterile PBS. Control (sham) mice were
injected with 30 Al sterile PBS alone.
Mononuclear cell isolation and flow cytometry
Mononuclear cells were obtained from the brains and
cervical lymph nodes [two draining cervical lymph nodes
(CLN) per mouse] of either CCL3+/+ or CCL3/ mice atdefined times post-infection (p.i.) using a previously
described protocol (Trifilo et al., 2003). Cell surface
expression of phenotypic markers was examined using the
following reagents for flow cytometric analysis: APC-
conjugated rat anti-mouse CD8; PERCP-conjugated rat anti
mouse CD4 (Pharmingen, San Diego, CA). PE conjugated
Db/S510–518 MHC class I tetramer (Beckman Coulter, San
Diego, CA) was utilized for identification of CD8+ T cells
specific for viral spike protein antigen (Trifilo et al., 2003).
To determine the presence of dendritic-like cells within the
CNS and lymph nodes, cells were stained using FITC-
conjugated rat anti-mouse CD11c (Serotec, Oxford, Eng-
land) in combination with PERCP-conjugated rat anti-mouse
CD8a (Pharmingen), rat anti-mouse APC-conjugated
CD11b (Pharmingen), and rat anti-mouse DEC205 (Phar-
mingen). The maturation and activation state of DC were
determined using FITC-conjugated rat anti-mouse CD40,
CD80, CD86, MHC I, and MHC II (Pharmingen). Isotype-
matched antibodies were used as controls for all staining
conditions described.
Isolation of CD11c+ cells from the CLN
CCL3+/+ and CCL3/ mice were infected intracrani-
ally with 1000 PFU of MHV and brains and CLN were
removed at defined times post-infection for analysis. Brain
samples were minced and homogenized into a single cell
suspension followed by fractionation on a 70/30% Percoll
gradient at 1300  g for 30 min. For isolation of
mononuclear cells from the CLN, lymph nodes were
homogenized using frosted glass slides and the resulting
single cell suspension was treated with sterile H2O to lyse
red blood cells. Due to the low frequency and numbers of
CD11c+ cells within the brain and CLN, samples from
three to six mice were pooled for each experiment. To
enrich for CD11c+CD11b+CD8a DCs, both brain and
CLN samples were separately magnetically sorted by
negative selection against CD8a using MACS microbeads
coated with anti-CD8a (Miltenyi Biotec, Auburn, CA)
according to the manufacturer’s instructions. CD11c+ cells
were then magnetically selected from the CD8a fraction
using MACS microbeads coated with anti-CD11c (Milte-
nyi). The resulting population was N90% pure for CD11c+
cells that were subsequently determined to be CD11b+ and
CD8a by flow cytometry (data not shown). MACS
enriched cells were then resuspended in DMEM supple-
mented with 10% FBS.
Cytokine and chemokine expression from CD11c+CD8a
cells
Freshly prepared CD11c+CD8a cells were isolated
from the CLN from CCL3+/+ and CCL3/ mice at day 7
p.i. and seeded into 96-well plate at a cell density of 2  105
cells/200 Al in DMEM containing 10% fetal bovine serum
(FBS, BioWhittaker, Walkersville, MD). Following isola-
M.J. Trifilo, T.E. Lane / Virology 327 (2004) 8–1514tion, cell viability was N95%. After 24 h, supernatants from
the samples were collected, and the level of IL-12, IL-10,
and CCL3 were determined using Quantikine M mouse
immunoassays kits (R&D Systems, Minneapolis, MN)
according to manufacturer’s specifications. Assays had a
minimum sensitivity of 5 pg/ml (IL-10 and IL-12p70) and
10 pg/ml (CCL3).
Intracellular cytokine staining
Mononuclear cells were obtained from the CLNs of
MHV-infected mice at defined times post-infection and
cytokine production by T cells determined by intracellular
cytokine staining to defined viral antigens using a previ-
ously described protocol (Trifilo et al., 2003).
Statistical analysis
Statistically significant differences between experimental
groups was determined by the Mann–Whitney Rank Sum
Test, and P values of V0.05 were considered significant.Acknowledgments
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